Sign In
Last checked at 
8 Aug 2018 14:21
08 August 2018
Kainos Group plc
("Kainos" or the "Company)
Director and PCA Dealing
The Company was notified on 08 August 2018 that Richard McCann, Director, has:
1. exercised his 2015 PSP options over 68,345 ordinary shares of £0.005 in the Company ("Ordinary Shares"), at an exercise price of £0.005 per Ordinary Share; and
2. exercised his 2015 SAYE options over 3,237 Ordinary Shares at an exercise price of £1.112 per Ordinary Share; and
3. received a nil value transfer of 100,000 Ordinary Shares from his spouse/Person Closely Associated ("PCA").
Following this notification, having retained the PSP and SAYE Ordinary Shares on exercise, Richard McCann and his PCA have a reportable shareholding of 6,211,582 Ordinary Shares in the issued share capital of the Company, constituting 5.19% of the issued share capital of the Company.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||||||||||||
a. | Name | Richard McCann | ||||||||||||||||||
2. | Reason for the notification | |||||||||||||||||||
a. | Position/status | COO/CFO & PDMR | ||||||||||||||||||
b. | Initial notification /Amendment | Initial notification | ||||||||||||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||||
a. | Name | Kainos Group plc | ||||||||||||||||||
b. | LEI | 213800H2PQMIF3OVZY47 | ||||||||||||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||||||||
a. | Description of the Financial instrument/ type of instrument Identification code | Ordinary Shares of £0.005 each
ISIN: GB00BZ0D6727 | ||||||||||||||||||
b. | Nature of the transaction | Exercise of Options and Retention of Shares Transfer of Shares from Spouse | ||||||||||||||||||
c. | Price(s) and volume(s) |
| ||||||||||||||||||
d. | Aggregated information · Aggregated volume · Price |
N/A | ||||||||||||||||||
e. | Date of the transaction | PSP exercise and transfer to spouse - 07 August 2018 SAYE exercise - 08 August 2018 | ||||||||||||||||||
f. | Place of the transaction | Outside a trading venue | ||||||||||||||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a. | Name | Kerry McCann | ||||||
2. | Reason for the notification | |||||||
a. | Position/status | PCA of Richard McCann (PDMR) | ||||||
b. | Initial notification /Amendment | Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a. | Name | Kainos Group plc | ||||||
b. | LEI | 213800H2PQMIF3OVZY47 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a. | Description of the Financial instrument/ type of instrument Identification code | Ordinary Shares of £0.005 each
ISIN: GB00BZ0D6727 | ||||||
b. | Nature of the transaction | Transfer to Spouse | ||||||
c. | Price(s) and volume(s) |
| ||||||
d. | Aggregated information · Aggregated volume · Price |
N/A | ||||||
e. | Date of the transaction | 07 August 2018 | ||||||
f. | Place of the transaction | Outside a trading venue | ||||||
Classification: Additional Regulated Information
Ends
For further information, please contact:
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Investec Bank plc 44 20 7597 5970
Patrick Robb / Sebastian Lawrence
Canaccord Genuity +44 20 7523 4606
Simon Bridges / Emma Gabriel
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Harry Staight
About Kainos
Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.
The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.
The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.
Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.
Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com
Follow the stocks
